Latest Vaccines news
FDA Adds Warning Label to RSV Vaccines Abrysvo and Arexvy
posted January 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
15.4 Percent of 0- to 35-Month-Olds Receive Invalid Vaccine Dose
posted January 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Eight in 10 Infants Received RSV Protection in the 2023 to 2024 Season
posted January 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Immunocompromised Have Heterogeneous Antibody Response to RSV Vaccines
posted January 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
Recurrent Visual Field Progression Happens for 1 in 4 With Glaucoma 
Lower Cognitive Functioning During 60s Linked to Subsequent Stroke Risk 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
Nearly 1 in 10 Older Adults Used Cannabis in the Past Year Related Articles
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia 
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease 
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
Trends Reported in Vaccination Coverage for Adolescents for 2025 Monthly Specialist Briefings
Stay Connected
